analysis of starpharma trading over the week

Even though the company finished week at 64 cents - the following should be noted

Total value of shares over the week $1,577,522
Total volume of shares over the week 2,400,724

Based on these figures - vwap (value weighted average price) was 65.712620 cents. This is above the capital raising price

Also please note the short selling over the week

Monday  22nd September - 193,355 shares short sold (share price range 69-65)

Tuesday 23rd September - 10,412 shares short sold (share price range 67-64.5)

Wednesday 24th September - 13,285 shares short sold (share price range 67-64)

Thursday 25th September - 5,587 shares short sold (share price range 65-63.5)

Friday 26th September - unknown ( however would assume hardly any due to share price below SPP price) share price range 65-63

I suspect shorting of stock is almost complete now. On Monday there was a 4 cent difference between the then current share price (69 cents) and share purchase plan price (65 cents). That is why in my opinion there was 193,355 shares shorted. It makes total sense. However as the share price got closer to the SPP price of 65 cents - shorting decreased substantially.

I also believe there is absolutely no reason now to short stock. In fact those shorters should in my opinion start covering at around these levels. The announcement in regards to Ansell and Okamoto starting to retail out Vivagel coated condom will definitely be the catalyst of a wild swing upwards

The other catalysts which I hope are close is the commercialisation of Starpharma Agrochemical products

Starpharma is indeed in an exciting phase of growth from my perspective

I also believe irrespective of world market indices that floor over coming weeks will be 65 cents

Of course once again the above is my opinion and should not be construed as investment advice